CPXCX | CPXZX | CPXCX / CPXZX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 10 years | - |
Gain YTD | 9.507 | 10.499 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.89B | 7.89B | 100% |
Annual Yield % from dividends | 4.76 | 5.66 | 84% |
Returns for 1 year | 14.65 | 15.82 | 93% |
Returns for 3 years | -0.19 | 2.87 | -7% |
Returns for 5 years | 9.12 | 14.82 | 62% |
Returns for 10 years | 41.60 | 56.44 | 74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JPVRX | 14.67 | 0.02 | +0.14% |
JPMorgan Developed International ValueR5 | |||
BAEIX | 28.36 | -0.24 | -0.84% |
Sterling Capital Equity Income A | |||
GIRGX | 22.78 | -0.29 | -1.26% |
Goldman Sachs U.S. Equity ESG Inv | |||
POIIX | 15.69 | -0.22 | -1.38% |
Polen International Growth Institutional | |||
SHSKX | 72.26 | -1.74 | -2.35% |
BlackRock Health Sciences Opps K |